Lung Kee (Bermuda) Holdings Limited, an investment holding company, manufactures and markets mold bases and related products in the People’s Republic of China and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$3.59|
|52 Week High||HK$2.33|
|52 Week Low||HK$4.02|
|1 Month Change||0.56%|
|3 Month Change||-2.71%|
|1 Year Change||48.96%|
|3 Year Change||9.12%|
|5 Year Change||33.46%|
|Change since IPO||243.71%|
Recent News & Updates
Lung Kee (Bermuda) Holdings (HKG:255) Is Increasing Its Dividend To HK$0.15
Lung Kee (Bermuda) Holdings Limited ( HKG:255 ) will increase its dividend on the 28th of September to HK$0.15. This...
|255||HK Machinery||HK Market|
Return vs Industry: 255 exceeded the Hong Kong Machinery industry which returned 21.1% over the past year.
Return vs Market: 255 exceeded the Hong Kong Market which returned 5.7% over the past year.
Stable Share Price: 255 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 255's weekly volatility (3%) has been stable over the past year.
About the Company
|n/a||3,500||Yuk Lung Siu|
Lung Kee (Bermuda) Holdings Limited, an investment holding company, manufactures and markets mold bases and related products in the People’s Republic of China and internationally. The company is headquartered in Sha Tin, Hong Kong. Lung Kee (Bermuda) Holdings Limited is a subsidiary of Pan Island Investments Limited.
Lung Kee (Bermuda) Holdings Fundamentals Summary
|255 fundamental statistics|
Is 255 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|255 income statement (TTM)|
|Cost of Revenue||HK$887.23m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.35|
|Net Profit Margin||9.66%|
How did 255 perform over the long term?See historical performance and comparison
9.2%Current Dividend Yield
Is Lung Kee (Bermuda) Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 255 (HK$3.59) is trading below our estimate of fair value (HK$13.33)
Significantly Below Fair Value: 255 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 255 is good value based on its PE Ratio (10.2x) compared to the Hong Kong Machinery industry average (11.8x).
PE vs Market: 255 is poor value based on its PE Ratio (10.2x) compared to the Hong Kong market (9.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 255's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 255's PB Ratio (1x) is in line with the HK Machinery industry average.
How is Lung Kee (Bermuda) Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Capital Goods industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lung Kee (Bermuda) Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Lung Kee (Bermuda) Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 255 has high quality earnings.
Growing Profit Margin: 255's current net profit margins (9.7%) are higher than last year (6.9%).
Past Earnings Growth Analysis
Earnings Trend: 255's earnings have declined by 5.2% per year over the past 5 years.
Accelerating Growth: 255's earnings growth over the past year (51.7%) exceeds its 5-year average (-5.2% per year).
Earnings vs Industry: 255 earnings growth over the past year (51.7%) exceeded the Machinery industry 23.8%.
Return on Equity
High ROE: 255's Return on Equity (10%) is considered low.
How is Lung Kee (Bermuda) Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 255's short term assets (HK$1.7B) exceed its short term liabilities (HK$390.5M).
Long Term Liabilities: 255's short term assets (HK$1.7B) exceed its long term liabilities (HK$128.8M).
Debt to Equity History and Analysis
Debt Level: 255 is debt free.
Reducing Debt: 255 had no debt 5 years ago.
Debt Coverage: 255 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 255 has no debt, therefore coverage of interest payments is not a concern.
What is Lung Kee (Bermuda) Holdings's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 255's dividend (9.19%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.25%).
High Dividend: 255's dividend (9.19%) is in the top 25% of dividend payers in the Hong Kong market (6.81%)
Stability and Growth of Payments
Stable Dividend: 255's dividend payments have been volatile in the past 10 years.
Growing Dividend: 255's dividend payments have fallen over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (93.9%), 255's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Yuk Lung Siu (67 yo)
Mr. Yuk Lung Siu has been the Managing Director of Lung Kee Bermuda Holdings Ltd., since December 1992. Mr. Siu Co-founded Lung Kee Bermuda Holdings Ltd. He serves as the Managing Director of Lung Kee Meta...
CEO Compensation Analysis
Compensation vs Market: Yuk Lung's total compensation ($USD1.28M) is above average for companies of similar size in the Hong Kong market ($USD296.59K).
Compensation vs Earnings: Yuk Lung's compensation has been consistent with company performance over the past year.
Experienced Board: 255's board of directors are seasoned and experienced ( 17.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Lung Kee (Bermuda) Holdings Limited's employee growth, exchange listings and data sources
- Name: Lung Kee (Bermuda) Holdings Limited
- Ticker: 255
- Exchange: SEHK
- Founded: NaN
- Industry: Industrial Machinery
- Sector: Capital Goods
- Market Cap: HK$2.280b
- Shares outstanding: 631.68m
Number of Employees
- Lung Kee (Bermuda) Holdings Limited
- Unit A, Kings Wing Plaza 2
- 15th Floor
- Sha Tin
- New Territories
- Hong Kong
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/22 10:05|
|End of Day Share Price||2021/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.